HRTX · Heron Therapeutics, Inc. /De/

$0.31 -0.01 (-1.87%) At close · Aug 20

Market Cap

$59.78M

189.85M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-14	2026-08-13
8-K	2026-08-10	—
10-Q	2026-08-10	2026-06-30
Investor Event Transcript	2026-06-30	—
8-K	2026-06-25	—
8-K	2026-06-16	2026-06-11
8-K	2026-06-02	—
8-K	2026-05-11	—
10-Q	2026-05-11	2026-03-31
DEF 14A	2026-04-30	—
8-K	2026-04-06	2026-04-03
10-K	2026-02-26	2025-12-31
8-K	2026-02-26	—
8-K	2026-01-09	—
10-Q	2025-11-04	2025-09-30
8-K	2025-11-04	—
8-K	2025-10-29	2025-10-27
8-K	2025-10-15	—
DEF 14A	2025-09-19	2025-10-13
8-K	2025-08-28	2025-08-22
8-K	2025-08-15	2025-08-13
8-K	2025-08-12	2025-08-08
8-K	2025-08-12	2025-08-06
10-Q	2025-08-08	2025-06-30
8-K	2025-08-08	—
8-K	2025-06-18	2025-06-12
8-K	2025-05-06	—
8-K	2025-05-06	—
10-Q	2025-05-06	2025-03-31
DEF 14A	2025-04-30	2025-06-12
8-K	2025-04-29	2025-04-28
8-K	2025-02-27	—
10-K	2025-02-27	2024-12-31
8-K	2025-02-20	2025-02-13
8-K	2024-12-23	—
8-K	2024-12-03	—
10-Q	2024-11-12	2024-09-30
8-K	2024-11-12	—
8-K	2024-11-04	—
10-Q	2024-08-06	2024-06-30
8-K	2024-08-06	—
8-K	2024-07-02	—
8-K	2024-06-18	2024-06-13
8-K	2024-05-29	—
10-Q	2024-05-07	2024-03-31
8-K	2024-05-07	—
DEF 14A	2024-04-29	2024-06-13
8-K	2024-03-21	2024-03-18
8-K	2024-03-12	—
10-K	2024-03-12	2023-12-31

Showing 1–50 of 131 filings

Key facts CIK 818033 CUSIP 427746102 13F (30d) 148 filings 148 filers Visit website Investor relations